Third Dose Of COVID-19 Vaccine Neutralises Omicron Variant - Pfizer/Biontech

Pfizer and BioNTech say initial lab studies show a third dose of their Covid-19 vaccine neutralizes the omicron variant. Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers

Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection